1 Introduction to Research & Analysis Reports
    1.1 Insomnia Therapeutics Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Insomnia Therapeutics Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Insomnia Therapeutics Drugs Overall Market Size
    2.1 Global Insomnia Therapeutics Drugs Market Size: 2021 VS 2027
    2.2 Global Insomnia Therapeutics Drugs Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Insomnia Therapeutics Drugs Players in Global Market
    3.2 Top Global Insomnia Therapeutics Drugs Companies Ranked by Revenue
    3.3 Global Insomnia Therapeutics Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Insomnia Therapeutics Drugs Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Insomnia Therapeutics Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Insomnia Therapeutics Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Insomnia Therapeutics Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Insomnia Therapeutics Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Insomnia Therapeutics Drugs Market Size Markets, 2021 & 2027
        4.1.2 Benzodiazepines
        4.1.3 Nonbenzodiazepines
        4.1.4 Antidepressants
        4.1.5 Orexin Antagonists
        4.1.6 Melatonin Antagonists
        4.1.7 Others
    4.2 By Type - Global Insomnia Therapeutics Drugs Revenue & Forecasts
        4.2.1 By Type - Global Insomnia Therapeutics Drugs Revenue, 2016-2021
        4.2.2 By Type - Global Insomnia Therapeutics Drugs Revenue, 2022-2027
        4.2.3 By Type - Global Insomnia Therapeutics Drugs Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Insomnia Therapeutics Drugs Market Size, 2021 & 2027
        5.1.2 Prescription
        5.1.3 Over-the-Counter (OTC)
    5.2 By Application - Global Insomnia Therapeutics Drugs Revenue & Forecasts
        5.2.1 By Application - Global Insomnia Therapeutics Drugs Revenue, 2016-2021
        5.2.2 By Application - Global Insomnia Therapeutics Drugs Revenue, 2022-2027
        5.2.3 By Application - Global Insomnia Therapeutics Drugs Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Insomnia Therapeutics Drugs Market Size, 2021 & 2027
    6.2 By Region - Global Insomnia Therapeutics Drugs Revenue & Forecasts
        6.2.1 By Region - Global Insomnia Therapeutics Drugs Revenue, 2016-2021
        6.2.2 By Region - Global Insomnia Therapeutics Drugs Revenue, 2022-2027
        6.2.3 By Region - Global Insomnia Therapeutics Drugs Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Insomnia Therapeutics Drugs Revenue, 2016-2027
        6.3.2 US Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.3.3 Canada Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.3.4 Mexico Insomnia Therapeutics Drugs Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Insomnia Therapeutics Drugs Revenue, 2016-2027
        6.4.2 Germany Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.4.3 France Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.4.4 U.K. Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.4.5 Italy Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.4.6 Russia Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.4.7 Nordic Countries Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.4.8 Benelux Insomnia Therapeutics Drugs Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Insomnia Therapeutics Drugs Revenue, 2016-2027
        6.5.2 China Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.5.3 Japan Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.5.4 South Korea Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.5.5 Southeast Asia Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.5.6 India Insomnia Therapeutics Drugs Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Insomnia Therapeutics Drugs Revenue, 2016-2027
        6.6.2 Brazil Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.6.3 Argentina Insomnia Therapeutics Drugs Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Insomnia Therapeutics Drugs Revenue, 2016-2027
        6.7.2 Turkey Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.7.3 Israel Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.7.4 Saudi Arabia Insomnia Therapeutics Drugs Market Size, 2016-2027
        6.7.5 UAE Insomnia Therapeutics Drugs Market Size, 2016-2027
7 Players Profiles
    7.1 Takeda Pharmaceutical Company Ltd.
        7.1.1 Takeda Pharmaceutical Company Ltd. Corporate Summary
        7.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
        7.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Major Product Offerings
        7.1.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue in Global (2016-2021)
        7.1.5 Takeda Pharmaceutical Company Ltd. Key News
    7.2 Vanda Pharmaceuticals
        7.2.1 Vanda Pharmaceuticals Corporate Summary
        7.2.2 Vanda Pharmaceuticals Business Overview
        7.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Major Product Offerings
        7.2.4 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue in Global (2016-2021)
        7.2.5 Vanda Pharmaceuticals Key News
    7.3 Merck & Co., Inc.
        7.3.1 Merck & Co., Inc. Corporate Summary
        7.3.2 Merck & Co., Inc. Business Overview
        7.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Major Product Offerings
        7.3.4 Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue in Global (2016-2021)
        7.3.5 Merck & Co., Inc. Key News
    7.4 Pfizer Inc.
        7.4.1 Pfizer Inc. Corporate Summary
        7.4.2 Pfizer Inc. Business Overview
        7.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Major Product Offerings
        7.4.4 Pfizer Inc. Insomnia Therapeutics Drugs Revenue in Global (2016-2021)
        7.4.5 Pfizer Inc. Key News
    7.5 Teva Pharmaceutical Industries Ltd.
        7.5.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
        7.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
        7.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Major Product Offerings
        7.5.4 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue in Global (2016-2021)
        7.5.5 Teva Pharmaceutical Industries Ltd. Key News
    7.6 Mylan N.V.
        7.6.1 Mylan N.V. Corporate Summary
        7.6.2 Mylan N.V. Business Overview
        7.6.3 Mylan N.V. Insomnia Therapeutics Drugs Major Product Offerings
        7.6.4 Mylan N.V. Insomnia Therapeutics Drugs Revenue in Global (2016-2021)
        7.6.5 Mylan N.V. Key News
    7.7 Sumitomo Dainippon Pharma Co., Ltd
        7.7.1 Sumitomo Dainippon Pharma Co., Ltd Corporate Summary
        7.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
        7.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Major Product Offerings
        7.4.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue in Global (2016-2021)
        7.7.5 Sumitomo Dainippon Pharma Co., Ltd Key News
    7.8 Sanofi
        7.8.1 Sanofi Corporate Summary
        7.8.2 Sanofi Business Overview
        7.8.3 Sanofi Insomnia Therapeutics Drugs Major Product Offerings
        7.8.4 Sanofi Insomnia Therapeutics Drugs Revenue in Global (2016-2021)
        7.8.5 Sanofi Key News
    7.9 Paratek Pharmaceuticals Inc.
        7.9.1 Paratek Pharmaceuticals Inc. Corporate Summary
        7.9.2 Paratek Pharmaceuticals Inc. Business Overview
        7.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Major Product Offerings
        7.9.4 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue in Global (2016-2021)
        7.9.5 Paratek Pharmaceuticals Inc. Key News
    7.10 Ebb Therapeutics
        7.10.1 Ebb Therapeutics Corporate Summary
        7.10.2 Ebb Therapeutics Business Overview
        7.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Major Product Offerings
        7.10.4 Ebb Therapeutics Insomnia Therapeutics Drugs Revenue in Global (2016-2021)
        7.10.5 Ebb Therapeutics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer